• PTEN mRNA Reinstatement: Redefining Oncology with EZ Cap™

  2026-07-14

  Explore the mechanistic and translational advances enabled by EZ Cap™ Human PTEN mRNA (ψUTP), a pseudouridine-modified, Cap1-structured in vitro transcribed mRNA. This article contextualizes its superiority for cancer research, especially in overcoming PI3K/Akt-driven resistance, and provides actionable protocol guidance for translational researchers.

• Hemagglutinin mRNA Vaccine Protects Dairy Cows from H5N1

  2026-07-13

  This study establishes that a hemagglutinin-based mRNA–lipid nanoparticle vaccine provides robust and durable protection against H5N1 influenza in lactating dairy cows, with no adverse effects on health or milk production. The research highlights the promise of mRNA vaccine platforms for large livestock and their potential in mitigating zoonotic influenza threats.

• GTP Solution in mRNA Synthesis: Catalyzing Translational Bla

  2026-07-13

  Explore how high-purity GTP Solution (100 mM) enables next-generation mRNA synthesis for localized bladder cancer therapy. This article connects mechanistic insight, workflow innovation, and translational impact—highlighting recent advances in p21 mRNA-LNP delivery, experimental best practices, and strategic guidance for researchers seeking clinical relevance.

• Flubendazole: Autophagy Modulation Tool for Cancer & Fibrosi

  2026-07-12

  Flubendazole (methyl N-[6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamate) is a high-purity autophagy activator widely used in cancer biology and cellular degradation research. Its robust DMSO solubility and well-characterized mechanism make it a benchmark for autophagy modulation studies. Recent evidence links autophagy regulation with metabolic pathways relevant to liver fibrosis and cancer.

• Ruthenium Red: Applied Workflows for Ca2+ Transport Inhibiti

  2026-07-10

  Ruthenium Red stands out as a high-affinity Ca2+ transport inhibitor, enabling precise dissection of calcium signaling and mechanotransduction in advanced cell models. This guide translates recent breakthroughs in cytoskeleton-dependent autophagy into actionable experimental strategies, troubleshooting insights, and protocol enhancements for cutting-edge calcium pathway research.

• LY-411575: Advanced Insights into Gamma-Secretase Inhibition

  2026-07-09

  Explore how LY-411575, a potent gamma-secretase inhibitor, enables precise modulation of amyloid beta and Notch pathways for Alzheimer's and cancer research. This article delivers new assay strategies and critical analysis beyond existing guides.

• EZ Cap™ Cas9 mRNA (m1Ψ): Precision Genome Editing with Cap1

  2026-07-09

  EZ Cap™ Cas9 mRNA (m1Ψ) is a Cap1-structured, N1-Methylpseudo-UTP modified mRNA optimized for high-efficiency CRISPR-Cas9 genome editing. Its design enhances translation, suppresses innate immune responses, and increases stability for robust results in mammalian cells.

• Reliable Cell Assays with EZ Cap™ Firefly Luciferase mRNA (R

  2026-07-08

  This article addresses persistent laboratory challenges in cell viability, proliferation, and reporter assays using EZ Cap™ Firefly Luciferase mRNA (SKU R1018). Through scenario-driven analysis and protocol guidance, researchers will discover how this Cap 1-structured mRNA enables reproducible, sensitive, and workflow-safe bioluminescent readouts for translational and molecular biology applications.

• ARCA EGFP mRNA: Precision Reporter for Transfection Control

  2026-07-08

  ARCA EGFP mRNA empowers robust, fluorescence-based assays for quantifying transfection efficiency and optimizing gene delivery in mammalian cells. Its advanced ARCA capping and optimized poly(A) tail deliver unmatched stability and expression, making it indispensable for both routine and mechanistic studies.

• Deferasirox Modulates Myeloid Differentiation via NF-κB and

  2026-07-07

  Jeffries et al. uncover how deferasirox, an iron chelator, influences myeloid cell differentiation by regulating NF-κB activity through mitochondrial ROS modulation. Their work delineates stage-specific effects of deferasirox on progenitors and neutrophils, illuminating mechanisms relevant to iron overload treatment research and hematopoietic biology.

• Intravesical p21 mRNA-LNP Therapy for Bladder Cancer: Mechan

  2026-07-07

  This study introduces a localized, non-viral approach using p21 mRNA-loaded lipid nanoparticles (LNPs) for intravesical tumor suppressor replacement in bladder cancer. The findings demonstrate robust tumor inhibition, restoration of p21 expression, and minimal systemic toxicity, suggesting a promising direction for targeted mRNA-based therapies in urologic oncology.

• Guanabenz Acetate: Applied Workflows for α2-Adrenergic Recep

  2026-07-06

  Guanabenz Acetate, a highly selective α2-adrenergic receptor agonist, empowers researchers to dissect GPCR signaling and stress granule biology with precision. Here, we detail robust experimental workflows, practical troubleshooting, and strategic insights for leveraging this tool in neuroscience and innate immunity research.

• Translating Proteasome Inhibition: MG-262 in Muscle Aging Re

  2026-07-06

  This thought-leadership article explores the mechanistic and translational applications of MG-262 (Z-Leu-Leu-Leu-B(OH)2), a reversible proteasome inhibitor, in the context of skeletal muscle proteostasis and age-related myopathy. Bridging new findings on chaperone-mediated autophagy decline with strategic assay design, it guides researchers in leveraging MG-262 for mechanistic, cell cycle, and apoptosis studies, while contextualizing its competitive position and translational impact.

• Estradiol–Receptor–Autophagy Axis in Perimenopausal Organ Pr

  2026-07-05

  This study reveals how declining estradiol levels during perimenopause elevate cardiometabolic and renal risk, and demonstrates that estrogen’s protective role operates through coordinated receptor signaling and autophagy. By combining human cohort analysis with mouse experiments and network pharmacology, the research identifies key molecular pathways that may inform precision hormone therapy strategies.

• Morning Endurance Training Enhances Adaptation in Mice

  2026-07-04

  Hesketh et al. (2026) demonstrate that endurance training during the early active phase (morning) in mice produces more efficient performance adaptations compared to afternoon training, despite lower training volumes. These findings underscore the influence of exercise timing on physiological adaptation, with implications for experimental design in circadian and metabolic research.

483 records 7/33 page Previous Next First page 上5页 678910 下5页 Last page